Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 3;123(4):477-494.
doi: 10.1161/CIRCRESAHA.118.313237.

Emerging Roles of Vascular Endothelium in Metabolic Homeostasis

Affiliations
Review

Emerging Roles of Vascular Endothelium in Metabolic Homeostasis

Xinchun Pi et al. Circ Res. .

Abstract

Our understanding of the role of the vascular endothelium has evolved over the past 2 decades, with the recognition that it is a dynamically regulated organ and that it plays a nodal role in a variety of physiological and pathological processes. Endothelial cells (ECs) are not only a barrier between the circulation and peripheral tissues, but also actively regulate vascular tone, blood flow, and platelet function. Dysregulation of ECs contributes to pathological conditions such as vascular inflammation, atherosclerosis, hypertension, cardiomyopathy, retinopathy, neuropathy, and cancer. The close anatomic relationship between vascular endothelium and highly vascularized metabolic organs/tissues suggests that the crosstalk between ECs and these organs is vital for both vascular and metabolic homeostasis. Numerous reports support that hyperlipidemia, hyperglycemia, and other metabolic stresses result in endothelial dysfunction and vascular complications. However, how ECs may regulate metabolic homeostasis remains poorly understood. Emerging data suggest that the vascular endothelium plays an unexpected role in the regulation of metabolic homeostasis and that endothelial dysregulation directly contributes to the development of metabolic disorders. Here, we review recent studies about the pivotal role of ECs in glucose and lipid homeostasis. In particular, we introduce the concept that the endothelium adjusts its barrier function to control the transendothelial transport of fatty acids, lipoproteins, LPLs (lipoprotein lipases), glucose, and insulin. In addition, we summarize reports that ECs communicate with metabolic cells through EC-secreted factors and we discuss how endothelial dysregulation contributes directly to the development of obesity, insulin resistance, dyslipidemia, diabetes mellitus, cognitive defects, and fatty liver disease.

Keywords: diabetes mellitus; endothelial cells; insulin resistance; metabolic homeostasis; obesity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Trans-endothelial transport of FAs, lipoprotein, glucose and insulin.
Figure 2.
Figure 2.
Metabolic regulation by endothelial cell-secreted factors.

Similar articles

Cited by

References

    1. Levick JR. An introduction to cardiovascular physiology. 5th ed. London: Hodder Arnold; 2010.
    1. Sherwood L and Cengage Learning (Firm). Human physiology: from cells to systems. 7th ed. Australia; United States: Brooks/Cole, Cengage Learning; 2010.
    1. Tuma RF, Durán WN and Ley K. Microcirculation. 2nd ed. Amsterdam; Boston: Elsevier/Academic Press; 2008.
    1. Granger DN and Senchenkova E. Inflammation and the microcirculation San Rafael (CA); 2010. - PubMed
    1. Simon SI, Sarantos MR, Green CE and Schaff UY. Leucocyte recruitment under fluid shear: mechanical and molecular regulation within the inflammatory synapse. Clin Exp Pharmacol Physiol. 2009;36:217–24. - PubMed

Publication types